Retina South Africa

Retina South Africa is the only patient group in South Africa dedicated to bringing promising clinical trials and treatments to South Africa. We offer free counselling, education, information and referrals to patients with retinal genetic vision loss and facilitate genetic testing.

Retina South Africa was established in 1980 as the South African Retinitis Pigmentosa Society.

Retina South Africa is a patient-driven action group that has offices or groups in all the major centres in South Africa.  Our major focus is:

  • Support of the Retinal Degeneration Research project at the University of Cape Town to find the genetic mutations in South African families
  • Facilitation of genetic testing to identify those patients who will benefit from clinical trials and imminent therapy
  • Public Awareness of retinal degeneration
  • Patient support including education, referral and intervention
  • Collaboration with local and international agencies and researchers
  • Fundraising to support this work

We are founding members of Retina International with headquarters in Ireland.

Membership is open to all patients, family members and persons who wish to support our quest to find treatments for retinal blinding conditions.

Address

Postnet Suite 75
Private Bag X10020
Edenvale, 1610
South Africa

Contact

T 0027114501181

E headoffice@retinasa.org.za
E claudette@retinasa.org.za
www.retinasa.org.za

Newsletter

To keep up to date with our news and activities,
please leave your details below

Please indicate your consent for Retina International to contact you via the email address listed for the purposes of general alerts and newsletters.

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.